Dan, IMHO your concerns are genuine - I suspect th

Dan, IMHO your concerns are genuine - I suspect that with the extreme roller coaster ride in share price as of recent, directly tied to communication misque's involving both AAIC and C4TC conferences, GC would have been provided a dire wake up call regarding his public relationship skills.

While I believe that AMBS has a whale at the table regarding a LymPro JV Agreement, I also have to temper my convictions, as I have seen AMBS wanting to hold control over the entire pipeline, as opposed to allowing anyone in the family's 'garden wall'. This could well change if it were a J&J or/= with $50-Mil. upfront and they were proactive on bringing this deal to fruition.

What I'm genuinely looking forward to over the next 5 weeks are the following:

1.) LymPro bridge data above 90%
2.) LymPro JV Partnership announcement
3.) 2Q14 CC w/ LymPro revenue guidance
4.) MANF orphan update
5.) Eltoprazine 1st patient in trial announcement

Bottom line is I have choosen to trust GC & CO. with the family farm. The science to simply too compelling and at the ned of the day, we all mature as we grow....